Journal profile · GASTROENTEROLOGY & HEPATOLOGY
Clinical and Experimental Hepatology
ISSN 2392-1099 · eISSN 2449-8238 · Termedia Publishing House Ltd.
Clinical and Experimental Hepatology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2 (journal website); fully open access; APC charged, amount not published; median 62 days to acceptance (58 articles, last 24 months); 44 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Clinical and Experimental Hepatology is published by Termedia Publishing House Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Liver Disease Diagnosis and Treatment, Hepatitis C virus research and Liver Disease and Transplantation, together about 40.9% of its articles. Its main subfields are Hepatology. (generated from OpenAlex topic counts and CAS ranking data)
Clinical and Experimental Hepatology – quarterly of the Polish Association for Study of Liver – is a scientific and educational, peer-reviewed journal publishing original and review papers describing clinical and basic investigations in the field of hepatology.
From the journal's Aims & Scope
Research area (LetPub): GASTROENTEROLOGY & HEPATOLOGY
Editorial board by country: none in mainland China; most named Poland 17, France 2, Slovakia 2, India 1, Italy 1 (28 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Liver Disease Diagnosis and TreatmentMedicine17.9%
- Hepatitis C virus researchMedicine11.7%
- Liver Disease and TransplantationMedicine11.3%
- Hepatitis B Virus StudiesMedicine7.3%
- Liver Diseases and ImmunityMedicine6.3%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine5.6%
- Organ Transplantation Techniques and OutcomesMedicine5%
- Hepatitis Viruses Studies and EpidemiologyMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Integrated with Editorial PoliciesPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2Publisher website ·
- CiteScore 2026-06
- 3LetPub ·
- SJR 2026-06
- 0.47LetPub ·
- SNIP 2026-06
- 0.63LetPub ·
- h-index
- 31OpenAlex ·
- i10-index
- 120OpenAlex ·
- 2-year mean citedness
- 1.41OpenAlex ·
- Self-citation rate
- 5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 44LetPub ·
Articles by year OpenAlex count · 450 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 28 | 28 | 2 |
| 2025 | 44 | 44 | 57 |
| 2024 | 39 | 39 | 98 |
| 2023 | 46 | 46 | 344 |
| 2022 | 43 | 43 | 263 |
| 2021 | 57 | 57 | 560 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
62 daysMedian, submission to acceptance · P25–P75 38 days – 86 days
- Acceptance to online
- median 121 days (58 articles)
- Submission to online
- median 182 days
- Sample
- 58 articles with submission and acceptance dates (75 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to acceptance
- 7 daysPublisher website ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | PLN 4,250 / EUR 1,000 | Yes | CC BY-NC-SA | |
| Publisher website | EUR 1,000 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted5
- editorialsEditorials are written on invitation and should have an unstructured abstract of up to 150 words.Length not stated
- original paperOriginal paperLength not stated
- original papersOriginal papers should be structured in the following order: Introduction, Material and methods, Results, Discussion, Conclusions, Acknowledgments and Disclosur…Length not stated
- review articlesReview articles should follow the format for a regular article and should contain unstructured abstract containing no more than 150 words and up to 5 key words.Length not stated
- review paperReview paperLength not stated
Policy excerpts from the journal's websiteAuthorship, Open access, Peer review, Plagiarism
- Authorship
Originality of manuscripts in accordance with ICMJE and WAME criteria. Model summary
The journal applies procedures ensuring the originality of manuscripts in accordance with the criteria of the ICMJE (International Committee of Medical Journal Editors) and WAME (World Association of Medical Editors).
Source ↗Publisher website ·- Open access
Open access publication. Model summary
The articles in this journal are published open access (OA).
Source ↗Publisher website ·- Peer review
Double-blinded peer review process. Model summary
The Clinical and Experimental Hepatology has always used a double-blinded peer review process.
Source ↗Publisher website ·- Plagiarism
Zero tolerance for plagiarism, ghostwriting, and guest authorship. Model summary
The Clinical and Experimental Hepatology will not tolerate plagiarism in any form. All cases of ghostwriting and guest authorship will be liable for customary penalty as an indication of scientific negligence.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Termedia Publishing House Ltd.
- ISSN
- 2392-1099
- Electronic ISSN
- 2449-8238
- Society / sponsor
- Polish Association for Study of Liver
- Latest issue on the website
- Volume 12 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Clinical and Experimental Hepatology
What CAS zone is Clinical and Experimental Hepatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical and Experimental Hepatology is in Zone 4 of Medicine, and in Zone 4 of the minor category Gastroenterology & Hepatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical and Experimental Hepatology?
The journal's website gives an impact factor of 2; this is the journal's own figure, as LetPub lists none for it; CiteScore 3, h-index 31.
How long does peer review take at Clinical and Experimental Hepatology?
Based on the dates recorded on 58 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 62 days (interquartile range 38–86 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Clinical and Experimental Hepatology based?
Of the 28 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Poland (17), France (2) and Slovakia (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical and Experimental Hepatology?
According to LetPub and DOAJ records, Clinical and Experimental Hepatology is indexed in ESCI, Scopus and DOAJ.
Is Clinical and Experimental Hepatology open access, and what is the APC?
Clinical and Experimental Hepatology is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .